# ALTERITY THERAPEUTICS LTD (ATHE)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ATHE/

- Reporting holders: 3
- Reported value: $6.1K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $5.2K | 1,426 | 0.0% | 4 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $858 | 236 | 0.0% | 5 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $77 | 21 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $6.1K |
| Q2 2026 | 22 | $2.3M |
| Q1 2026 | 15 | $1.1M |
| Q4 2025 | 17 | $1.0M |
| Q3 2025 | 16 | $1.3M |
| Q2 2025 | 11 | $906.9K |
| Q1 2025 | 12 | $833.9K |
| Q4 2024 | 13 | $415.9K |
| Q3 2024 | 13 | $148.6K |
| Q2 2024 | 10 | $140.9K |
| Q1 2024 | 10 | $409.0K |
| Q4 2023 | 9 | $363.8K |